1-N'-(4-fluorophenyl)-1-N'-[4-[6-[5-(hydroxyamino)-5-oxopentoxy]-7-methoxyquinolin-4-yl]oxyphenyl]cyclopropane-1,1-dicarboxamide

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 1-N'-(4-fluorophenyl)-1-N'-[4-[6-[5-(hydroxyamino)-5-oxopentoxy]-7-methoxyquinolin-4-yl]oxyphenyl]cyclopropane-1,1-dicarboxamide
• 化学式: C₃₂H₃₁FN₄O₇
• 分子量: 602.6
• InChiKey: LAMVMGXYBTYORW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  44
• 可旋转键数：
  13
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  153
• 氢给体数：
  3
• 氢受体数：
  9

文献信息

• Quinolyl-containing Hydroxamic Acid Compound and Preparation Method Thereof, and Pharmaceutical Composition Containing This Compound and Use Thereof
  申请人：Yun Ziwei

  公开号：US20140221425A1

  公开（公告）日：2014-08-07

  Provided in the present invention is a quinolyl-containing hydroxamic acid compound as shown in formula (I), at the same time also disclosed is the preparation method of the compound and the use thereof, and a pharmaceutical composition containing the quinolyl-containing hydroxamic acid compound. Such compounds are inhibitors of protein kinases and/or histone deacetylases, and can be used in the treatment of diseases caused by the abnormal activity of protein kinases and/or histone deacetylases, for example, tumors, etc.

  本发明提供了一种含有喹啉基羟肟酸化合物，如式（I）所示，同时还揭示了该化合物的制备方法及其用途，以及含有该含有喹啉基羟肟酸化合物的药物组合物。这些化合物是蛋白激酶和/或组蛋白去乙酰化酶的抑制剂，可用于治疗由蛋白激酶和/或组蛋白去乙酰化酶异常活动引起的疾病，例如肿瘤等。
• HYDROXAMIC ACID COMPOUND CONTAINING QUINOLYL AND PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THIS COMPOUND AND USE THEREOF
  申请人：Beijing Konruns Pharmaceutical Co., Ltd.

  公开号：EP2769976B1

  公开（公告）日：2017-08-02
• US9186318B2
  申请人：——

  公开号：US9186318B2

  公开（公告）日：2015-11-17